Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer | Naviance

Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

LEARN MORE

Recent Posts

Novel Bone Marrow Transplant Can Cure Sickle Cell Disease Scientists Identify Epigenetic Key That ‘Opens’ Door to Colon Cancer Co-located Cell Types Help Drive Aggressive Brain Tumors US surgeon general sounds alarm about link between alcohol and cancer Researchers Develop Biomarker Algorithm for Barrett’s Esophagus and Esophageal Cancer Scientists Identify New Epigenetic Approach to Target Colorectal Cancer Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers How Hypoxia Helps Cancer Spread